Cholesteryl ester storage disease (Q53741): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 01:18, 14 August 2026
Cholesteryl ester storage disease is the term used to group together deficiencies in lysosomal acid lipase associated with a less severe clinical phenotype than that seen in Wolman disease (see this term), with a continuous clinical spectrum between early-onset and severe forms and those that are quasi-asymptomatic, which may reflect variations in the levels of residual acid lipase activity in vivo.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_894336362 |
||
| English | Cholesteryl ester storage disease |
Cholesteryl ester storage disease is the term used to group together deficiencies in lysosomal acid lipase associated with a less severe clinical phenotype than that seen in Wolman disease (see this term), with a continuous clinical spectrum between early-onset and severe forms and those that are quasi-asymptomatic, which may reflect variations in the levels of residual acid lipase activity in vivo. |
Statements
CID11:ID_894336362
0 references
dki-india-ID_894336362
0 references
Concluído
0 references
13 August 2026
0 references
